Trial Profile
Real-world Comparative Effectiveness of Apixaban Versus VKA
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2017
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms PIXI-F
- Sponsors Bayer
- 23 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 24 Feb 2016 New trial record